Cigna Group (NYSE:CI) Insider Nicole Jones Sells 2,677 Shares
Cigna Group insider Nicole Jones sold 2,677 shares of the company's stock for approximately $748,516 under a pre-arranged Rule 10b5-1 plan, reducing her ownership by 9.37%. This transaction was disclosed in a legal filing with the SEC. Despite the insider selling, Cigna's latest quarterly results beat earnings expectations, and analysts maintain a "Moderate Buy" consensus with an average price target of $339.45.
Stryker Corp Stock (SYK) Closed Down by 3.61% on Aug 20: A Full Analysis
Stryker Corp (SYK) stock closed down by 3.61% on August 20, experiencing profit-taking despite a recent U.S. defense contract modification. Investors remain concerned about operational disruptions, cyber incident costs, supply chain bottlenecks, and the company's ambitious second-half revenue guidance. Despite strong fundamentals and analyst consensus, short-term trading dynamics are influenced by macro-level sector rotations and valuation reassessments.
Intuitive Surgical Inc Stock (ISRG) Moved Down by 4.89% on Aug 20: What Signal Does It Send?
Intuitive Surgical Inc (ISRG) stock fell by 4.89% due to concerns over increasing competition in the robotic-assisted surgery market, regulatory clearances for rival systems, and a cautious full-year guidance despite strong operational metrics. Wall Street analysts also revised price targets downward, reflecting hospital capital expenditure caution and broader market anxieties. Technical indicators show a mix of buy, neutral, and sell signals, with low media attention and generally bullish market sentiment.
Can Humana's Star Ratings Rebound Unlock MA Earnings Power?
Humana Inc. (HUM) is focusing on improving its Medicare Advantage (MA) Star Ratings to drive earnings growth and achieve a sustainable pretax margin of at least 3% by 2028. Early efforts show promising results in clinical quality and member engagement, with the upcoming October CMS Stars release being a crucial test. A successful rebound could significantly enhance MA plan economics and investor confidence, while peers like UnitedHealth Group (UNH) and Elevance Health (ELV) also prioritize MA quality.
UnitedHealth Group stock holds steady as healthcare sector hits record high
UnitedHealth Group stock is trading below its recent peak despite the S&P 500 healthcare sector reaching a record high, driven by strong investor appetite. The company's diverse operations, including UnitedHealthcare insurance and the Optum services platform, along with its consistent dividend stream, support its position as a key player in the healthcare market. Investors are closely watching its profit margins and long-term capital-return policy, with analysts suggesting potential upside from its current share price.
Costco Expands Into Senior Health Care
Costco Wholesale Corp. is expanding its partnership with SCAN Health Plan to offer Costco-branded Medicare plans, marking its first comprehensive alliance with a Medicare provider. This initiative aims to provide seniors with integrated health coverage including pharmacy services, vision, hearing, and over-the-counter benefits. The move builds on an existing collaboration and seeks to make healthcare more accessible and value-driven for older adults.
UnitedHealth Group Incorporated $UNH Holdings Boosted by Simplicity Wealth LLC
Simplicity Wealth LLC significantly increased its stake in UnitedHealth Group (UNH) by 156.7% in Q2, bringing its total holdings to 31,667 shares valued at $13.2 million. Institutional investors and hedge funds collectively own 87.86% of the company, and analysts maintain a "Moderate Buy" rating with an average price target of $455.92. UnitedHealth also reported strong quarterly EPS of $6.38, exceeding estimates, and declared a quarterly dividend of $2.32 per share.
UnitedHealth Group Incorporated $UNH Shares Sold by Longfellow Investment Management Co. LLC
Longfellow Investment Management Co. LLC significantly reduced its stake in UnitedHealth Group (NYSE:UNH) by 40.6% in the second quarter, selling 2,684 shares, though institutional investors still hold 87.86% of the company. Despite this sale, analysts maintain a "Moderate Buy" rating with an average price target of $455.92, and the company recently beat earnings expectations with an EPS of $6.38. UnitedHealth also declared a quarterly dividend of $2.32 per share, reinforcing its capital-return appeal.
Plato Investment Management Ltd Purchases 4,863 Shares of UnitedHealth Group Incorporated $UNH
Plato Investment Management Ltd increased its stake in UnitedHealth Group (UNH) by 26.6%, purchasing an additional 4,863 shares to bring its total holdings to 23,178 shares valued at $9.6 million. UnitedHealth reported strong Q2 earnings, exceeding revenue and EPS estimates, and reaffirmed its fiscal 2026 EPS guidance. Analysts generally maintain a "Moderate Buy" rating for UNH, despite the stock opening lower and facing regulatory risks.
CareCloud confirms massive data breach after 3.7M patients’ records stolen – What we know
CareCloud has confirmed a massive data breach that compromised the medical and personal records of over 3.7 million patients. The March cyberattack, which involved hackers accessing and removing data from CareCloud’s Amazon Web Services account, is now the fifth-largest US healthcare data theft of 2026. Stolen information includes names, addresses, Social Security numbers, medical records, government IDs, and financial details, leaving affected individuals vulnerable to identity theft and fraud.
17,720 Shares in CVS Health Corporation $CVS Acquired by Foster & Motley Inc.
Foster & Motley Inc. recently acquired 17,720 shares of CVS Health Corporation, valued at approximately $1.83 million. This comes as other institutional investors have also adjusted their holdings in the pharmacy operator. CVS Health reported strong quarterly earnings and announced a dividend, while analysts maintain a "Moderate Buy" consensus rating with an average price target of $107.17.
Diversify Advisory Services LLC Invests $1.52 Million in Cigna Group $CI
Diversify Advisory Services LLC has invested $1.52 million in Cigna Group (NYSE:CI) by purchasing 5,230 shares in the second quarter. Cigna has received a "Moderate Buy" rating from analysts with an average price target of $339.45, reflecting positive sentiment. The company also reported strong quarterly earnings, beating expectations, and declared a quarterly dividend of $1.56.
First National Bank of Omaha Takes Position in Humana Inc. $HUM
First National Bank of Omaha has acquired 2,766 shares of Humana Inc. (NYSE:HUM) stock, valued at approximately $1.099 million, during the second quarter. This move is part of a broader trend of institutional investors modifying their holdings in Humana, with significant increases from Vanguard Group, BlackRock Inc., and Capital International Investors. Analysts currently have a consensus "Hold" rating on Humana with a target price of $395.22, following various upgrades and price target adjustments.
Danske Bank A S Purchases New Position in Humana Inc. $HUM
Danske Bank A S has acquired a new position in Humana Inc. (NYSE:HUM) during the second quarter, purchasing 61,897 shares valued at approximately $24.59 million. This makes Danske Bank A S the owner of about 0.05% of Humana. Other institutional investors have also adjusted their holdings in Humana, while analysts have provided varied ratings, with a consensus "Hold" and a price target of $395.22.
Global Retirement Partners LLC Buys Shares of 23,702 UnitedHealth Group Incorporated $UNH
Global Retirement Partners LLC has acquired 23,702 shares of UnitedHealth Group (NYSE:UNH) valued at approximately $9.85 million during the second quarter. This investment comes as UnitedHealth Group reported strong quarterly earnings, beating analyst expectations, and maintaining its fiscal 2026 guidance. Analyst sentiment remains positive with a "Moderate Buy" rating and a $455.92 average price target, despite an insider sale by CEO Patrick Hugh Conway.
Bank of New York Mellon Corp Purchases 616,723 Shares of UnitedHealth Group Incorporated $UNH
Bank of New York Mellon Corp increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 6.1% during the second quarter, purchasing an additional 616,723 shares. This makes UnitedHealth Group the 22nd biggest position in their investment portfolio, valued at approximately $4.45 billion. Other institutional investors also adjusted their holdings, while analysts maintain a "Moderate Buy" rating for UNH with an average price target of $455.92.
Alberta Investment Management Corp Makes New $17.62 Million Investment in UnitedHealth Group Incorporated $UNH
Alberta Investment Management Corp recently acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH), purchasing 42,400 shares valued at approximately $17.62 million. Several other institutional investors also adjusted their holdings in UnitedHealth Group. Analysts have issued various ratings and price targets for UNH, with a consensus of "Moderate Buy" and an average target price of $455.92.
Target Corporation (TGT) vs. Walmart (WMT): A Closer Look at Two Dividend Giants
This article compares Target (TGT) and Walmart (WMT) as dividend investments, highlighting their different income profiles and dividend growth potential. Target offers a higher current yield but has a smaller cash flow cushion and relies more on a retail turnaround, while Walmart provides a lower yield but boasts a stronger cash flow, more defensive business model, and greater flexibility for future dividend increases. The choice depends on an investor's preference for current income versus long-term dividend reliability.
Danaher Corp Stock (DHR) Closed Up by 6.16% on Aug 19: A Full Analysis
Danaher Corp (DHR) stock rose by 6.16% on August 19, driven by strong institutional confidence following positive quarterly earnings and the appointment of Julie Sawyer Montgomery as the new CEO. The company's revenue and adjusted earnings surpassed Wall Street estimates, and its strategic execution, including the Masimo Corporation acquisition, contributed to its upward momentum. Despite some technical indicators suggesting neutrality or a sell condition, fundamental analysis highlights solid financial performance and favorable analyst ratings.
UnitedHealth Stock And 2 Dividend Names For Investors Seeking Stability
Amid rising bankruptcy filings and recession warnings, this article identifies three dividend-focused healthcare stocks for investors seeking stability: Abbott Laboratories (ABT), Elevance Health (ELV), and UnitedHealth Group (UNH). These companies offer defensive traits, recurring revenues, and established dividend records, making them potential candidates for portfolios looking for steadier ground in a volatile market. The article details each company's business model, revenue streams, and factors influencing their dividend profiles and financial stability.
Oracle Health upgrades AI agent with coding, charting features
Oracle Health has expanded the capabilities of its Clinical AI Agent to include automated professional fee coding support, dictation features, and AI-assisted chart review. These upgrades aim to reduce manual work for clinicians, mitigate inaccuracies, and increase efficiency by integrating AI directly into clinical and revenue cycle workflows. The move comes as EHR companies continue an "AI arms race," with competitors like Epic also launching new AI-based functionalities to enhance clinical decision-making and streamline tasks.
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.67% on Aug 19: Facts Behind the Movement
Thermo Fisher Scientific Inc. (TMO) saw its stock rise by 3.67% on August 19, driven by strong Q2 financial results, strategic portfolio optimization including the sale of its microbiology business, and significant institutional investor interest. The company outperformed its sector, with analysts maintaining a largely bullish consensus. Despite technical indicators showing mixed signals and some insider sales, the overall sentiment remains positive due to improving end-market demand and sound execution.
UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?
UnitedHealth (UNH) is trading at 18.39X forward 12-month earnings, below its five-year median P/E, suggesting a modest discount despite being above the industry average. The company has shown improved medical care ratios and upward earnings estimate revisions, with analysts seeing further upside. However, regulatory scrutiny, potential tax issues, and membership declines pose ongoing risks.
Resmed Inc Stock (RMD) Moved Up by 3.43% on Aug 19: What Investors Need To Know
Resmed Inc (RMD) saw its stock price increase by 3.43% due to positive investor sentiment surrounding capital allocation milestones, increased dividends, and the divestiture of its MatrixCare business. Technical indicators like MACD and Williams %R suggest a buy signal, while fundamental analysis highlights its solid annual revenue and net profit within the Healthcare Services & Equipment industry. Despite some company-specific risks like ventilator product recalls and market share erosion, investor confidence is bolstered by the company's strategic realignments and resilient core demand for sleep apnea devices.
Oracle Health Expands Clinical AI Agent with Automated Coding, Dictation, and Chart Review
Oracle Health has enhanced its Clinical AI Agent with new capabilities in the U.S. that include automated professional fee coding, direct dictation for clinicians, and AI-powered chart review. These advancements aim to streamline clinical documentation, improve revenue cycle workflows, and provide relevant patient context to help healthcare organizations operate more efficiently and allow clinicians to focus on patient care. The company reports that its AI agent has already saved physicians over 400,000 hours in note generation.
UnitedHealth Stock Looks Reasonable at 18.39X P/E: Should You Buy Now?
UnitedHealth (UNH) stock is trading at 18.39X forward 12-month earnings, below its five-year median but above the industry average, suggesting a premium for its strong market position. The company has seen improved medical costs, upward earnings estimate revisions for 2026 and 2027, and significant capital returns to shareholders. Despite ongoing regulatory scrutiny and potential membership declines, the stock carries a Zacks Rank #2 (Buy) due to its favorable risk-reward profile and solid fundamentals.
Costco enters the Medicare Advantage market through SCAN partnership
Costco Wholesale Corporation is partnering with SCAN Health Plan to enter the Medicare Advantage market. This collaboration will involve selling Medicare Advantage products in two states and a Medicare supplement in a third, along with plans for integrated benefits like pharmacy experience and Medflex over-the-counter benefits, pending regulatory approval. This expanded alliance marks Costco's first comprehensive partnership with a Medicare Plan, aiming to offer a suite of senior-focused insurance products and services.
|‘Ultimately it’s going to be a great financial decision’: UHS CEO speaks on Talkspace bet
|Universal Health Services (UHS), the largest behavioral health provider in the U.S., recently acquired Talkspace for $835 million, marking a significant expansion into virtual services. CEO Marc Miller believes this acquisition will provide an "end-to-end continuum" of behavioral health services, addressing unmet demand and offering diverse options to patients. Despite current challenges in the hospital sector and recent stock downgrades for UHS, Miller is confident in the long-term financial success and strategic advantage of this investment.
Q1 EPS Forecast for UnitedHealth Group Lifted by Analyst
Zacks Research has increased its Q1 2027 EPS forecast for UnitedHealth Group (NYSE:UNH) to $7.12, maintaining a "Strong Buy" rating. The healthcare conglomerate recently reported Q1 earnings of $6.38 per share, surpassing the consensus estimate, and revenue of $112.03 billion, also exceeding expectations. Analyst sentiment remains largely positive, with a "Moderate Buy" consensus rating and an average price target of $455.92 for UNH.
Wealthfront Advisers LLC Sells 12,937 Shares of Stryker Corporation $SYK
Wealthfront Advisers LLC reduced its stake in Stryker Corporation by 25.5% in the second quarter, selling 12,937 shares and retaining 37,818 shares valued at approximately $11.9 million. Despite this, institutional investors collectively own 77.09% of Stryker, and analysts maintain a "Moderate Buy" rating with an average price target of $386.28. The company recently exceeded earnings expectations with $3.69 EPS and $6.59 billion in revenue, and declared a quarterly dividend of $0.88 per share.
UnitedHealth Group Incorporated $UNH Shares Bought by Kelleher Financial Advisors
Kelleher Financial Advisors significantly increased its stake in UnitedHealth Group (UNH) by 135.9% in the second quarter, now holding 5,495 shares valued at $2.28 million. Institutional investors and hedge funds collectively own 87.86% of UNH. Despite positive analyst ratings and strong quarterly earnings, the company faces ongoing risks from governance, cybersecurity, and AI-related coverage-denial lawsuits.
Private Advisory Group LLC Decreases Position in UnitedHealth Group Incorporated $UNH
Private Advisory Group LLC reduced its stake in UnitedHealth Group Incorporated by 7.9% in the second quarter, selling 3,461 shares and holding 40,598 shares valued at $16.9 million. UnitedHealth reported strong quarterly EPS of $6.38, exceeding estimates, with revenue of $112.03 billion, and reaffirmed its fiscal 2026 EPS guidance. Despite broad analyst optimism and a "Moderate Buy" rating, the company faces potential legal and reputational risks from shareholder lawsuits concerning governance, cybersecurity, and AI-driven coverage denials.
190,044 Shares in CVS Health Corporation $CVS Bought by Wealthfront Advisers LLC
Wealthfront Advisers LLC has acquired a new position in CVS Health Corporation, purchasing 190,044 shares valued at approximately $19.66 million during the second quarter. This move comes as CVS reported strong Q2 results, exceeding analyst expectations with EPS of $2.58 and revenue of $106.1 billion, leading to a raised 2026 operating income outlook. The company also maintains a "Moderate Buy" rating from analysts with a consensus price target of $106.75 and a quarterly dividend of $0.665 per share.
290,935 Shares in Humana Inc. $HUM Acquired by Mitsubishi UFJ Asset Management Co. Ltd.
Mitsubishi UFJ Asset Management Co. Ltd. has acquired a new stake of 290,935 shares in Humana Inc. (NYSE:HUM), valued at approximately $115.56 million. Other large institutional investors have also adjusted their holdings in Humana. The stock currently holds a "Hold" consensus rating from analysts with a price target of $395.22, and it recently reported strong Q2 earnings, exceeding revenue and EPS expectations.
Russell Investments Group Ltd. Boosts Stake in UnitedHealth Group Incorporated $UNH
Russell Investments Group Ltd. increased its stake in UnitedHealth Group (UNH) by 11% in the second quarter, now holding 1.4 million shares valued at $581.6 million. Despite a recent sale of 500 shares by the CEO, analysts largely maintain a "Moderate Buy" rating with a consensus price target of $455.92. The company, which recently reported strong EPS of $6.38 and authorized a $2.32 quarterly dividend, faces ongoing litigation risks related to governance, cybersecurity, and coverage denials.
Stoneridge Investment Partners LLC Trims Stock Holdings in UnitedHealth Group Incorporated $UNH
Stoneridge Investment Partners LLC significantly reduced its stake in UnitedHealth Group Incorporated by 55.3% in the second quarter, selling 3,430 shares and retaining 2,778 shares valued at $1.15 million. This move comes as UnitedHealth reported strong quarterly earnings, beating revenue and EPS estimates, and announced a quarterly dividend of $2.32. Despite positive analyst ratings and a "Moderate Buy" consensus, the company faces legal challenges from shareholder lawsuits concerning governance, cybersecurity, and AI-related coverage denials, which pose reputational risks.
Great Lakes Advisors LLC Makes New Investment in CVS Health Corporation $CVS
Great Lakes Advisors LLC has acquired a new stake of 98,261 shares in CVS Health Corporation, valued at approximately $10.17 million. This investment comes as CVS Health reported strong second-quarter earnings, beating analyst estimates with an EPS of $2.58 and revenue of $106.1 billion, and raised its fiscal 2026 adjusted operating income outlook. Institutional investors collectively own 80.66% of CVS Health, which maintains a "Moderate Buy" consensus rating from analysts with an average price target of $106.75 and offers an annualized dividend yield of 2.8%.
Humana Inc. $HUM Shares Sold by Handelsbanken Fonder AB
Handelsbanken Fonder AB reduced its stake in Humana Inc. by 73.6% in the second quarter, selling 9,256 shares and retaining 3,321 shares valued at approximately $1.32 million. Despite this, institutional investors and hedge funds still own 92.38% of Humana's outstanding shares, with several increasing their positions. Humana reported strong quarterly results, beating EPS estimates and seeing a 26.2% revenue increase year-over-year, leading to an average analyst rating of "Hold" with a price target of $395.22.
Danske Bank A S Buys Shares of 890,499 CVS Health Corporation $CVS
Danske Bank A S has acquired a significant new position in CVS Health Corporation, purchasing 890,499 shares valued at approximately $92.1 million. This investment comes as CVS Health reported strong second-quarter results, exceeding revenue and EPS expectations, and raised its 2026 adjusted operating income outlook. Analysts maintain a "Moderate Buy" rating for CVS, with institutional investors collectively owning over 80% of the company's stock.
Focus Partners Advisor Solutions LLC Grows Stake in UnitedHealth Group Incorporated $UNH
Focus Partners Advisor Solutions LLC increased its stake in UnitedHealth Group Incorporated (UNH) by 50.8% in Q2, bringing their total to 17,805 shares valued at $7.4 million. Despite UnitedHealth exceeding Q2 earnings and revenue estimates and maintaining a "Moderate Buy" consensus, the company faces multiple lawsuits regarding governance, cybersecurity, and AI-related coverage denials, which could increase regulatory and reputational risks. Other institutional investors also modified their holdings, with collective institutional ownership now at 87.86%.
Centric Wealth Management Raises Position in UnitedHealth Group Incorporated $UNH
Centric Wealth Management significantly increased its stake in UnitedHealth Group (UNH) by 80.1% in the second quarter, bringing its total holdings to 39,178 shares valued at $15.2 million. The healthcare conglomerate reported strong quarterly EPS of $6.38 and revenue of $112.03 billion, while maintaining its 2026 EPS guidance. Despite a "Moderate Buy" consensus from analysts and a declared quarterly dividend, the company faces legal and reputational risks from ongoing shareholder lawsuits concerning governance, cybersecurity, and AI-related coverage denials.
ABN AMRO Bank N.V. Boosts Stake in UnitedHealth Group Incorporated $UNH
ABN AMRO Bank N.V. significantly increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 988.5% in the second quarter, now owning 13,291 shares valued at $5.56 million. Other institutional investors like Norges Bank and T. Rowe Price Investment Management Inc. have also made substantial investments in the healthcare conglomerate. The article details analyst ratings, insider trading activity, and the company's recent financial performance, including its dividend announcement and key news impacting the stock.
Alamar Capital Management LLC Purchases New Holdings in HCA Healthcare, Inc. $HCA
Alamar Capital Management LLC has acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, purchasing 8,491 shares valued at approximately $3.31 million. This investment now represents 1.7% of Alamar Capital Management LLC's portfolio, making it their 9th largest holding. Other institutional investors have also adjusted their positions in HCA Healthcare, which has shown recent stock growth and strong quarterly earnings, topping analyst expectations.
BEDY ETF | BNY Mellon Enhanced Dividend and Income ETF
This page provides an overview of the BNY Mellon Enhanced Dividend and Income ETF (BEDY), including its current stock price, key financial ratios like PE and PB, dividend yield, and top holdings. It also highlights the ETF's volume and the number of stocks it holds, along with a historical performance chart and calls to action for GuruFocus Premium Membership to access more detailed financial data and analysis tools.
Costco plots major expansion into senior healthcare with Medicare partnership
Costco is expanding significantly into senior healthcare by partnering with SCAN Health Plan to offer Medicare Advantage plans. This collaboration aims to provide a suite of senior-focused insurance products, including revamped pharmacy experiences, vision care, and audiology benefits. The initiative seeks to simplify healthcare access for seniors and will sell plans in Costco stores, through insurance agents, and online, pending regulatory approval.
UnitedHealth Group (UNH) vs. Eli Lilly and Company (LLY): Which Healthcare Stock Offers the Better Dividend?
This article compares UnitedHealth Group (UNH) and Eli Lilly and Company (LLY) as dividend stocks. UNH offers a higher current dividend yield and a longer history of dividend increases with a more reasonable valuation, making it suitable for income-focused investors. LLY, despite a lower current yield and higher valuation, presents stronger long-term dividend growth potential due to its rapidly expanding business and smaller payout relative to earnings.
UnitedHealth Group (UNH) vs. Eli Lilly and Company (LLY): Which Healthcare Stock Offers the Better Dividend?
This article compares UnitedHealth Group (UNH) and Eli Lilly and Company (LLY) as dividend investment options. UNH offers a higher current dividend yield, a longer history of dividend increases, and a more favorable valuation, making it a better choice for income-focused investors. LLY, despite a lower starting yield, presents a stronger dividend growth potential due to its rapid business expansion, appealing to investors prioritizing future payout increases.
Psyence Biomedical stock surges on Trump ibogaine announcement By Investing.com
Psyence Biomedical Ltd (NASDAQ:PBM) shares surged 22.5% after President Donald Trump announced the transfer of the University of Miami’s 1994 Ibogaine Investigational New Drug application to the federal government. This move is expected to accelerate ibogaine's development as a medical treatment, particularly for veterans with serious mental illness. Trump's administration is pushing for increased research, collaboration, and FDA guidance for psychedelic drugs like ibogaine.
UnitedHealth Group (UNH) Hit With Investor Lawsuit Over Governance And Cybersecurity Claims
UnitedHealth Group (UNH) is facing an investor lawsuit alleging corporate governance and cybersecurity failures related to its Change Healthcare acquisition. The lawsuit claims that oversight gaps at UnitedHealth contributed to what plaintiffs describe as the largest healthcare data breach in U.S. history, exposing sensitive patient data. This development raises questions for shareholders regarding how the company assesses and manages cybersecurity and acquisition risks, potentially impacting its financials and operations through legal settlements, fines, and increased security costs.
How a clinical-reasoning framework can help improve smaller AI models' performance
Researchers from Carnegie Mellon University, Weill Cornell Medicine, and Indiana University School of Medicine have developed a framework called Differential Reasoning Learning (DRL) to improve the performance of smaller, more affordable AI models in clinical decision-making. This framework compares smaller AI models against larger ones and human physicians' reasoning to identify and correct errors like omissions and hallucinations. The goal is to make high-quality AI more accessible and cost-effective for small and rural hospitals, especially for critical tasks like patient discharge decisions.
